中国微创外科杂志
中國微創外科雜誌
중국미창외과잡지
CHINESE JOURNAL OF MINIMALLY INVASIVE SURGERY
2014年
5期
436-438
,共3页
熊海云%曾小明%余明主%谭公祥%陈亚梅%郑慧杰%周刚标
熊海雲%曾小明%餘明主%譚公祥%陳亞梅%鄭慧傑%週剛標
웅해운%증소명%여명주%담공상%진아매%정혜걸%주강표
经皮肾镜取石术%输尿管结石%并发症
經皮腎鏡取石術%輸尿管結石%併髮癥
경피신경취석술%수뇨관결석%병발증
Percutaneous nephrolithotomy%Ureteral stones%Complication
目的:比较标准通道和微通道经皮肾镜取石术( percutaneous nephrolithotomy ,PCNL)治疗输尿管上段结石的临床效果。方法回顾性分析PCNL治疗67例输尿管上段结石的临床资料,根据不同工作通道分为标准通道组( n=36)和微通道组(n=31),比较2组手术时间、术后结石清除率、并发症等。结果2组在手术时间[(42.3±8.9) min vs.(46.3± 10.4) min,t=-1.697,P=0.095]、一期结石完全清除率[97.2%(35/36) vs.93.5%(29/31),χ2=0.018,P=0.894]、术后血红蛋白下降值[(12.3±4.9) g/L vs.(11.0±4.7)g/L,t=1.103,P=0.274]和住院时间[(6.4±1.0)d vs.(6.2±1.0)d,t=0.816,P=0.417]均无统计学差异。并发症发生率如输血[8.3%(3/36) vs.6.5%(2/31),χ2=0.000,P=1.000],发热[13.9%(5/36) vs.12.9%(4/31),χ2=0.000,P=1.000],输尿管穿孔[0 vs.3.2%(1/31),P=0.463]均无统计学差异。67例术后随访0.5~3年,平均1.2年,无肾功能丧失、肾周积液、复发性尿路感染、输尿管狭窄等。结论标准通道和微通道PCNL治疗输尿管上段结石的临床疗效与安全性无明显差别。
目的:比較標準通道和微通道經皮腎鏡取石術( percutaneous nephrolithotomy ,PCNL)治療輸尿管上段結石的臨床效果。方法迴顧性分析PCNL治療67例輸尿管上段結石的臨床資料,根據不同工作通道分為標準通道組( n=36)和微通道組(n=31),比較2組手術時間、術後結石清除率、併髮癥等。結果2組在手術時間[(42.3±8.9) min vs.(46.3± 10.4) min,t=-1.697,P=0.095]、一期結石完全清除率[97.2%(35/36) vs.93.5%(29/31),χ2=0.018,P=0.894]、術後血紅蛋白下降值[(12.3±4.9) g/L vs.(11.0±4.7)g/L,t=1.103,P=0.274]和住院時間[(6.4±1.0)d vs.(6.2±1.0)d,t=0.816,P=0.417]均無統計學差異。併髮癥髮生率如輸血[8.3%(3/36) vs.6.5%(2/31),χ2=0.000,P=1.000],髮熱[13.9%(5/36) vs.12.9%(4/31),χ2=0.000,P=1.000],輸尿管穿孔[0 vs.3.2%(1/31),P=0.463]均無統計學差異。67例術後隨訪0.5~3年,平均1.2年,無腎功能喪失、腎週積液、複髮性尿路感染、輸尿管狹窄等。結論標準通道和微通道PCNL治療輸尿管上段結石的臨床療效與安全性無明顯差彆。
목적:비교표준통도화미통도경피신경취석술( percutaneous nephrolithotomy ,PCNL)치료수뇨관상단결석적림상효과。방법회고성분석PCNL치료67례수뇨관상단결석적림상자료,근거불동공작통도분위표준통도조( n=36)화미통도조(n=31),비교2조수술시간、술후결석청제솔、병발증등。결과2조재수술시간[(42.3±8.9) min vs.(46.3± 10.4) min,t=-1.697,P=0.095]、일기결석완전청제솔[97.2%(35/36) vs.93.5%(29/31),χ2=0.018,P=0.894]、술후혈홍단백하강치[(12.3±4.9) g/L vs.(11.0±4.7)g/L,t=1.103,P=0.274]화주원시간[(6.4±1.0)d vs.(6.2±1.0)d,t=0.816,P=0.417]균무통계학차이。병발증발생솔여수혈[8.3%(3/36) vs.6.5%(2/31),χ2=0.000,P=1.000],발열[13.9%(5/36) vs.12.9%(4/31),χ2=0.000,P=1.000],수뇨관천공[0 vs.3.2%(1/31),P=0.463]균무통계학차이。67례술후수방0.5~3년,평균1.2년,무신공능상실、신주적액、복발성뇨로감염、수뇨관협착등。결론표준통도화미통도PCNL치료수뇨관상단결석적림상료효여안전성무명현차별。
Objective To compare the efficacy of standard-tract and mini-tract percutaneous nephrolithotomy ( PCNL) in the management of upper ureteral stones . Methods We carried out a retrospective analysis on the clinical data of 67 patients with upper ureteral stones undergoing PCNL .The patients were divided into standard-tract PCNL group ( n=36) and mini-tract PCNL group (n=31).The operative time, postoperative stone clearance rate and complications of the two groups were compared . Results No significant differences were observed in the operative time [(42.3 ±8.9) min vs.(46.3 ±10.4) min, t=-1.697, P=0.095], first-stage stone clearance rate [97.2%(35/36) vs.93.5%(29/31),χ2 =0.018, P=0.894], hemoglobin drop values [(12.3 ± 4.9) g/L vs.(11.0 ±4.7) g/L, t=1.103, P=0.274] and hospital stay [(6.4 ±1.0) d vs.(6.2 ±1.0) d, t=0.816, P=0.417] between the two groups .No significant difference in the incidence of complications such as blood transfusion [8.3% (3/36) vs.6.5%(2/31),χ2 =0.000, P=1.000], fever [13.9% (5/36) vs.12.9% (4/31), χ2 =0.000, P=1.000] and ureter perforation [0 vs.3.2%(1/31), P=0.463] was found between the two groups .All the patients were followed up for 6 months to 3 years with a mean of 1.2 years and no kidney dysfunction , hydroperinephrosis , recurrent urinary tract infection or ureter stenosis was observed. Conclusion The efficacy and safety of standard-tract and mini-tract percutaneous nephrolithotomy in the management of upper ureteral stones are comparable .